Quantcast

Latest Receptors Stories

2014-09-16 04:21:23

LONDON and BOSTON, September 16, 2014 /PRNewswire/ -- Heptares Therapeutics notes that its Chief Scientific Officer, Fiona Marshall, will give a presentation entitled "Structure-based Drug Design for G protein-coupled receptors using StaR(R) technology" as part of the inaugural "Advances in Drug Discovery and Development" virtual symposium run by Chemical & Engineering News, a publication of the American Chemical Society. The virtual symposium is on Wednesday, 24 September...

2014-09-10 04:21:30

LONDON and BOSTON, September 10, 2014 /PRNewswire/ -- Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, notes that members of its senior management team will present at the following industry events: 7th CNS Partnering & Deal-making Conference [https://www.gtcbio.com/conferences/cns-partnering-and-deal-making-overview ] (San Francisco, CA, USA, 18-19 September) Daniel Grau, Heptares President, will give a...

2014-08-18 23:06:24

New Human Aryl Hydrocarbon Receptor Reporter Assay System Kit State College, PA (PRWEB) August 18, 2014 INDIGO Biosciences, a research products and services company focused on nuclear receptor screenings, announced today that it has released new cell-based Aryl Hydrocarbon Receptor (AhR) reporter assay kits. The Aryl Hydocarbon Recepctor (AhR) Assay employs the luciferase reporter gene technology, and is used for screening test samples to quantify any functional activity that they may...

2014-08-04 09:37:10

Ecole Polytechnique Fédérale de Lausanne Neurons are the cells of our brain, spinal cord, and overall nervous system. They form complex networks to communicate with each other through electrical signals that are carried by chemicals. These chemicals bind to structures on the surface of neurons that are called neuroreceptors, opening or closing electrical pathways that allow transmission of the signal from neuron to neuron. One neuroreceptor, called 5HT3-R, is involved in conditions like...

DNA Origami Nano-tool Used To Provide Important Clue To Cancer
2014-07-08 03:57:36

Karolinska Institutet Researchers at Karolinska Institutet in Sweden have headed a study that has provided new knowledge about the EphA2 receptor, which is significant in several forms of cancer. This is important knowledge in itself – but just as important is how this study, which is published in the highly respected journal Nature Methods today, was conducted. The researchers used the method of DNA origami, in which a DNA molecule is shaped into a nanostructure, and used these...

2014-06-30 04:21:39

LONDON and BOSTON, June 30, 2014 /PRNewswire/ -- Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, is delighted to announce that Fiona Marshall, Heptares' Chief Scientific Officer and co-founder, has been invited to present at the Royal Society of Medicine Medical Innovations Summit. The event, which takes place on Saturday 5 July 2014 at The Royal Society of Medicine in London, UK, will feature presentations on pioneering...

2014-06-11 08:28:27

DATA FROM KINECT 1 AND KINECT 2 TARDIVE DYSKINESIA STUDIES SAN DIEGO, June 11, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced that on June 11, 2014, two scientific posters associated with its study of NBI-98854 in Phase IIb clinical trials of tardive dyskinesia patients, will be presented at the 2014 Annual Congress of Parkinson's Disease and Movement Disorders in Stockholm Sweden. This annual meeting brings together over 5,000 clinicians and...

2014-03-26 11:18:13

The problems people with autism have with memory formation, higher-level thinking and social interactions may be partially attributable to the activity of receptors inside brain cells, researchers at Washington University School of Medicine in St. Louis have learned. Scientists were already aware that the type of receptor in question was a potential contributor to these problems – when located on the surfaces of brain cells. Until now, though, the role of the same type of receptor...

2014-03-26 04:21:13

LONDON and BOSTON, March 26, 2014 /PRNewswire/ -- Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, notes that a company presentation to be given by its Chief Executive Officer, Malcolm Weir, at BioCentury Future Leaders in the Biotech Industry [https://www.biocentury.com/conferences/futureleaders/dates ] on 28 March 2014 will be webcast live. The presentation will take place at 9.30am ET in room 302/303 at the Millennium Broadway...

2014-03-07 08:25:11

LONDON and BOSTON, March 7, 2014 /PRNewswire/ -- Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, notes that its Chief Executive Officer, Malcolm Weir, will participate in a panel discussion entitled, "Addressing cognitive deficits across CNS disorders: Potential to improve overall functional outcomes and QoL" (2:45pm-3:45pm CET on 10 March) at BIO-Europe Spring 2014 [http://www.ebdgroup.com/bes/index.php ], which takes place in...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related